Trial Condition(s):

Multiple Sclerosis

Physical Disability in Patients Treated With Betaferon

Bayer Identifier:

14173

ClinicalTrials.gov Identifier:

NCT00873340

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To gather Observation data about physical disability progression, safety and adherence during the use of Betaferon in daily practice. Patients with any type of Multiple Sclerosis (MS) (MRRS) (PSMS), under treatment with Betaferon.Open Multicentric Observational study.24 months.Evaluation of physical disability in patients treated with Betaferon, using Kurtzke's expanded disability scale (EDSS) in biannual periods

Inclusion Criteria
- Patients with a first demyelinating event suggestive of MS, as well as patients with remittent recurrent MS (RRMS), secondary progressive MS (SPMS) and primary progressive MS (PPMS) will be able to join the study.
Exclusion Criteria
- Pregnancy
 - Patients with a history of hypersensitivity to natural or recombinant interferon-beta, human albumin or to any of the excipients
 - Patients with a history of severe depressive disorders and/or suicidal ideation
 - Patient with decompensated liver disease
 - Patient with epilepsy not adequately controlled by treatment

Trial Summary

Enrollment Goal
83
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, Colombia

Status
Completed
 

Trial Design